Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02097173 · ClinicalTrials.gov registry record · Phase 1
Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen
A Phase 1 study, sponsored by medac.
- Completed
- Registry status
- Phase 1
- Development phase
- 35
- Enrollment target
NCT02097173 is a Phase 1 study that has completed, run by medac. The registered enrollment target is 35 participants.
The verdict
NCT02097173, a Phase 1 study, has completed, sponsored by medac.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 35 participants
- Enrollment target
Study Summary
This study is conducted to assess the relative bioavailability of MTX administered subcutaneously via a prefilled pen (50mg/mL) compared with MTX administered via IM injection (25mg/mL).
Interventions
- DRUG Methotrexate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2013-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02097173
The ClinicalTrials.gov registry entry for NCT02097173 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is medac, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Methotrexate is the first listed.
NCT02097173 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02097173 about?
NCT02097173 is a clinical study titled "Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen". This study is conducted to assess the relative bioavailability of MTX administered subcutaneously via a prefilled pen (50mg/mL) compared with MTX administered via IM injection (25mg/mL).
What is the current status of trial NCT02097173?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 35 participants. The study started on 2013-05.
What interventions are being tested in trial NCT02097173?
The interventions under investigation include: Methotrexate (DRUG).
Who is sponsoring clinical trial NCT02097173?
This trial is sponsored by medac, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.